Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Family Physicians

Antibiotic Susceptibility of Bacterial Uro-Pathogens In Patients Attending Family Physicians (In Vitro Study)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02305342

Enrollment

350

Registered

2014-12-02

Start date

2014-11-30

Completion date

2015-02-28

Last updated

2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections (UTIs)

Keywords

Uncomplicated UTI, Enoxacin

Brief summary

This study is aiming to evaluate the sensitivity of uropathogens isolated in patients with community acquired UTI with Enoxacin in comparison to other antimicrobials. While Secondary objective is to study the spectrum of uropathogens responsible for community acquired UTI in local population

Detailed description

Mid stream , clean catch urine specimens of patients with uncomplicated community acquired UTI sent to microbiology labs by treating consultants from filter clinics for evaluation of pathogens will be utilized for sensitivity analysis. Only the first positive urine culture obtained per sample will be included in the analysis to eliminate any possibility of recurrence and nosocomial infection. The polymicrobial cultures and cultures with multidrug-resistant uropathogens will not be included in the analysis. Cultures with common contaminants, including coagulase-negative staphylococci and hemolytic streptococci, and cultures with Candida growth will be excluded. . Data points to be collected will be date of collection, computer generated Lab #, age, gender,list of cultured organisms, sensitivity of organisms with antibiotics.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Samples from primary care clinics from patients who reports UTI symptoms and in which uropathogens are isolated will be included.

Exclusion criteria

* Samples from specialized, hospitalized or catheterized patients.

Design outcomes

Primary

Measure	Time frame	Description
Sensitivity of Uropathogens	3 months	Sensitivity of identified organisms shall be noted by the zone size in millimeters of the cultured organisms. Sensitive, Intermediate and Resistant labels shall be used as per Clinical Laboratory Standard Institute (CLSI) guidelines.

Secondary

Measure	Time frame	Description
Common UTI pathogens	3 months	To enlist the number and names of identified uropathogens from urine cultures.

Countries

Pakistan

Outcome results